Keywords: solasia, first, drug, trial, initiated, japan, china
Solasia's first drug trial initiated in Japan; China next
Article | 23 March 2009
Tokyo, Japan-based Solasia Pharma KK, a developer of western oncology pharmaceuticals in-licensed for commercialization in Asian markets, has initiated a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
